Danaher (DHR) announced a planned Board change. Director John T. Schwieters will not stand for reelection at the 2026 annual meeting and will retire at that time. The company stated his decision was not due to any disagreement on operations, policies, or practices.
Following his retirement, the Board size will be reduced from thirteen to twelve members. This is a governance update with no operational or financial changes disclosed.
Danaher (DHR) insider Mitchell P. Rales reported stock sales on a Form 4. On 10/31/2025, he sold a total of 600,000 shares of common stock in three transactions at weighted average prices of $215.67, $216.26, and $217.17. He is listed as a Director and Officer (Chairman of Exec. Committee).
Following these sales, Rales directly owned 990,228 shares. Indirect holdings listed include 912,654 shares through the Mitchell P. Rales Family Trust, 25,671,000 shares through single-member LLCs, and 667 shares via a 401(k) plan. The filing also lists 3,256 shares held by a trust for his daughter, with Rales disclaiming beneficial ownership of those shares. Price ranges for the sales were disclosed as $215.00–$215.99, $216.00–$216.99, and $217.00–$217.66.
Danaher (DHR) reported a Form 4 for director Feroz Dewan.
On 10/31/2025, the reporting person acquired 153.431 phantom shares under the Non‑Employee Directors Deferred Compensation Plan at a reference price of $215.38. Following the acquisition, 1,859.516 derivative securities were beneficially owned, held directly. Phantom shares convert into common stock on a one‑for‑one basis upon distribution, and the amounts are fully vested.
Danaher (DHR) director Alan G. Spoon reported a routine equity compensation transaction. On 10/31/2025, he acquired 195.724 phantom shares under the Non‑Employee Directors Deferred Compensation Plan, tied to a reference closing price of $215.38. Following the transaction, he beneficially owned 30,367.495 derivative (phantom) shares, held directly.
Per the plan, phantom shares reflect deferred director fees and convert into Danaher common stock on a one‑for‑one basis upon distribution. The derivative shows a $0 conversion/exercise price, consistent with fee deferrals rather than an option grant.
Danaher Corporation reported a director’s Form 4 showing the acquisition of 160.891 phantom shares on 10/31/2025 under the Non-Employee Directors Deferred Compensation Plan. The plan converts deferred director fees (including dividend accruals) into notional shares using the NYSE closing price on the transaction date, listed as $215.38.
The phantom shares convert into common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in amounts deferred. Following the transaction, 6,888.48 derivative securities were beneficially owned.
Danaher (DHR) director Elias A. Zerhouni reported a routine deferred‑compensation transaction. On 10/31/2025, he acquired 203.472 phantom shares under the Non‑Employee Directors Deferred Compensation Plan, reflecting quarterly fee deferral.
The Plan converts deferred amounts into notional Danaher shares using the NYSE closing price; the filing lists $215.38 as the reference price. Phantom shares convert into common stock on a one‑for‑one basis upon distribution. Following this transaction, he beneficially owns 18,012.058 derivative securities, held directly.
Danaher (DHR): Director A. Shane Sanders reported the acquisition of 186.308 phantom shares on 10/31/2025 on a Form 4. The award was made under the Non-Employee Directors Deferred Compensation Plan, which converts deferred director fees (and dividend accruals) into notional shares based on the NYSE closing price on the quarterly date. The filing notes a reference closing price of $215.38.
Following this transaction, Sanders beneficially owned 2,536.686 derivative securities (phantom shares), held directly. Phantom shares convert into Danaher common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in all amounts deferred under the plan.
Danaher (DHR) reported a routine insider transaction: director Linda Filler acquired 13.208 phantom shares on 10/31/2025 under the company’s Non‑Employee Directors Deferred Compensation Plan. These notional units track Danaher common stock and are valued using the NYSE closing price of $215.38 on the transaction date.
The phantom shares convert into Danaher common stock on a one‑for‑one basis upon distribution, and the reporting person is fully vested under the plan. Following the transaction, Filler beneficially owned 8,903.266 derivative securities, reported as directly owned.
Danaher Corporation (DHR) reported an insider equity compensation update. Director Teri List acquired 11.322 phantom shares on 10/31/2025 under the Non-Employee Directors Deferred Compensation Plan, which converts deferred cash fees into notional Danaher common stock equivalents based on the closing price on the transaction date.
The filing lists a reference price of $215.38 per share, reflecting the NYSE closing price used for the quarter’s deferral calculation. Phantom shares convert into Danaher common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in amounts deferred under the plan. Following this transaction, Ms. List beneficially owned 7,631.994 derivative (phantom) shares, held directly.
Danaher (DHR) — Rule 144 notice of proposed sale. A holder filed to sell 600,000 shares of Danaher common stock through Monness, Crespi, Hardt & Co., Inc., with an aggregate market value of $128,406,000. The approximate sale date is 10/31/2025 on the NYSE.
The filing lists 706,349,563 shares outstanding. The seller originally acquired 1,900,000 shares on 06/11/2021 via a distribution from Capital Yield Corporation in connection with the liquidation of a closely held corporation.